2016 American Transplant Congress
Immunologic Basis for Immunocloaking.
1BREONICS Inc., Watervliet, NY; 2Plastic Surgery, University of Utrecht, Utrecht, Netherlands.
A novel organ-specific immunomodifying therapy referred to as immunocloaking (IC) provides protection from early allograft rejection without immunosuppressive drugs. The IC binds to the surfaces…2016 American Transplant Congress
NEAD Chains Do Not Disadvantage Blood Type O, Black, or Highly Sensitized Patients.
1UT, Toledo; 2UCSF, SF; 3SLU, St Louis; 4Stanford, Palo Alto; 5Arbor Res, Ann Arbor.
Introduction: NEAD chains raised concern that wait-listed blood type (BT) O patients and racial minorities would be disadvantaged by allocation of a non-directed donor (NDD)…2016 American Transplant Congress
Urinary Exosomal Annexin A1 Is a Predictive Biomarker of Post Kidney Transplant Complications.
IntroductionMonitoring of kidney allograft condition is important. We had exhibited non-invasive diagnostic modality of post-kidney transplant complications using urine exosomal and microvesicule (EMV) mRNA of…2016 American Transplant Congress
Cytokine Networks in Kidney Transplant Patients.
As key mediators of the intercellular communication, cytokines play a crucial role in many processes following transplantation, including inflammation, tissue regeneration, and anti-microbial defense. Locally…2016 American Transplant Congress
Renal Graft Survival According to Banff 2013 Diagnostic Categories in Indication Biopsies.
1Nephrology, Hospital del Mar, Barcelona, Spain; 2Pathology, Hospital del Mar, Barcelona, Spain.
The impact of acute rejection in kidney graft survival is well known, but the prognosis of other diagnosis is uncertain. We evaluated the frequency and…2016 American Transplant Congress
Gut Dysbiosis and Metabolic Disorders in Kidney Transplant Recipients.
IntroductionGut microbiota modifications (dysbiosis) have been observed in obese and/or diabetic patients. Kidney transplant recipients (KTR) are particularly exposed to the development of metabolic disorders,…2016 American Transplant Congress
Evaluating Associations Between Clinical and Psychosocial Risk Factors and Adverse Post-Transplant Events in High Risk Renal Transplant Recipients.
Kidney/Pancreas Transplant, Vanderbilt University Medical Center, Nashville, TN.
Kidney transplant recipients (KTRs) require a complex medical regimen in the post-transplant period that can be difficult to navigate and if not followed, significant complications…2016 American Transplant Congress
Similar Kidney Allograft and Patient Survival in Native Americans Despite Lower Rates of Living Donation and Longer Wait on the Deceased Donor List.
1Nephrology, Mayo Clinic Arizona, Phoenix; 2Transplant Surgery, Mayo Clinic Arizona, Phoenix.
Previous studies have shown that Native Americans (NAs) have decreased access and inferior outcomes following kidney transplantation. Reviewing our center's experience we wanted to assess…2016 American Transplant Congress
Long-Term Efficacy and Safety of Everolimus Based Immunosuppression on De Novo Kidney Transplantation with 7 Years Follow-Up.
Purpose: Long-term efficacy and safety of everolimus (EVR) based immunosuppression for de novo kidney transplant recipient who were involved in A1202 study from our institute…2016 American Transplant Congress
Acute Rejections and Incidence of De Novo DSA Depend on Donor Factors and Deceased Donor Kidney Associated Risk Assessed by the Kidney Donor Profile Index (KDPI).
Nephrology, Charite, Berlin, Germany.
Introduction: Little data exist analyzing the influence of donor kidney quality on the immunologic outcome and applying the KDPI in a European cohort.Methods: This retrospective…
- « Previous Page
- 1
- …
- 442
- 443
- 444
- 445
- 446
- …
- 531
- Next Page »